Molecular Templates to Prioritize Next-Generation ETB Candidates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
UPDATE: Molecular Templates (MTEM) PT Raised to $20 at Jefferies, Following Clinical Business Update
April 5, 2021 1:18 PM EDT(Updated - April 5, 2021 1:46 PM EDT)
(Updated to correct investment bank name, previously reported as Ladenburg. News update, share price reaction added.)
Jefferies analyst Roger Song raised the price target on Molecular Templates (NASDAQ: MTEM) to $20.00 (from $18.00) while maintaining a Buy rating.
As a... More
